Human pharmacology of narcotic antagonists.
Open Access
- 1 June 1979
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 7 (S3) , 287S-290S
- https://doi.org/10.1111/j.1365-2125.1979.tb04702.x
Abstract
1 Human studies at the Addiction Research Center enable narcotic antagonists to be classified into three subgroups: (1) nalorphine-like agents; (2) pure antagonists; and (3) morphine-like agents. 2 Six narcotic antagonists (pentazocine, nalbuphine, cyclazocine, butorphanol, propiram and buprenorphine) developed in recent years seem to have a lesser abuse potential than codeine or propoxyphene. 3 When adjusted for relative availability of the agents, epidemiological data shows that pentazocine is abused less than codeine or propoxyphene in the US. 4 Recent studies with buprenorphine indicate that this agent would find application both as an analgesic of low abuse potential and as a new type of drug for the treatment of addiction.Keywords
This publication has 7 references indexed in Scilit:
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978
- Evaluation of nalbuphine for abuse potentialClinical Pharmacology & Therapeutics, 1972
- Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in manClinical Pharmacology & Therapeutics, 1971
- Effects of short‐ and long‐term administration of pentazocine in manClinical Pharmacology & Therapeutics, 1970
- Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).1965
- DEMONSTRATION OF TOLERANCE TO AND PHYSICAL DEPENDENCE ON N-ALLYLNORMORPHINE (NALORPHINE)1965
- STUDIES ON HUMAN ADDICTION LIABILITY OF 2]-HYDROXY-5,9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN ) WIN 20,228 ) - WEAK NARCOTIC ANTAGONIST1964